Research map: The Diverse Roles of the MEF2 Transcription Factor Family in Tumor Progression and Emerging Therapeutic Opportunities

Back to the article

Papers in this map

  1. PROTAC targeted protein degraders: the past is prologue · Miklós Békés · 2022 · 3299 citations · Cited by this paper
  2. Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives · 2026 · Related
  3. Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation · Kathleen M. Sakamoto · 2001 · 2576 citations · Cited by this paper
  4. Advancing Human Placental Modeling Through Stem-Cell-Derived Trophoblast Organoids and Reprogramming Innovations · 2026 · Related
  5. MEF2: a central regulator of diverse developmental programs · Matthew J. Potthoff · 2007 · 853 citations · Cited by this paper
  6. The Role of Endothelial–Mesenchymal Transition (EndMT) in Aneurysm Formation · 2026 · Related
  7. MEF2: a calcium-dependent regulator of cell division, differentiation and death · Timothy A. McKinsey · 2002 · 696 citations · Cited by this paper
  8. Ectoine Inhibits IL-1β-Induced Inflammation by Suppressing the NF-κB Pathway in Chondrocytes and Alleviates Osteoarthritis in a Rat Model · 2026 · Related
  9. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases · Armin Lahm · 2007 · 587 citations · Cited by this paper
  10. Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels · 2026 · Related
  11. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases · Jianrong Lu · 2000 · 521 citations · Cited by this paper
  12. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies · 2026 · Related
  13. Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia · Irene Homminga · 2011 · 392 citations · Cited by this paper
  14. Evaluation of Early and Delayed Meloxicam Treatment Against Regulated Cell Death Pathways and ERK1/2 Phosphorylation in a Rat Model of Renal Ischemia–Reperfusion Injury · 2026 · Related
  15. CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor · Guiqi Zhu · 2023 · 342 citations · Cited by this paper
  16. Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies · 2026 · Related
  17. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function · Ana Carolina Coutinho Barbosa · 2008 · 318 citations · Cited by this paper
  18. Region-Specific Proteomic Profiles of Extracellular Vesicles (EVs) Derived from Human Macular and Peripheral RPE-Choroid Explants · 2026 · Related
  19. Transcriptional Repression by Histone Deacetylases in Plants · Xuncheng Liu · 2014 · 282 citations · Cited by this paper
  20. Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development. · 2025 · Related
  21. Regulation of MEF2 by Histone Deacetylase 4- and SIRT1 Deacetylase-Mediated Lysine Modifications · Xuan Zhao · 2005 · 263 citations · Cited by this paper
  22. Cdk5-Mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-Induced Apoptosis · Xiaoming Gong · 2003 · 261 citations · Cited by this paper
  23. TF-PROTACs Enable Targeted Degradation of Transcription Factors · Jing Liu · 2021 · 242 citations · Cited by this paper
  24. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations · Nathalie Le Meur · 2009 · 231 citations · Cited by this paper
  25. MEF2 transcription factors: developmental regulators and emerging cancer genes · Julia R. Pon · 2015 · 206 citations · Cited by this paper
  26. Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2 · Serge Grégoire · 2006 · 202 citations · Cited by this paper
  27. Mef2 and the skeletal muscle differentiation program · Michael V. Taylor · 2017 · 202 citations · Cited by this paper
  28. Antiapoptotic role of the p38 mitogen-activated protein kinase–myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation · Shu-ichi Okamoto · 2000 · 196 citations · Cited by this paper
  29. MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma · Carol Y. Ying · 2013 · 189 citations · Cited by this paper
  30. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation · Peter R. Wilker · 2008 · 180 citations · Cited by this paper
  31. Regulatory Role of MEF2D in Serum Induction of the c- jun Promoter · Tae-Hee Han · 1995 · 175 citations · Cited by this paper
  32. Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation · Serge Grégoire · 2005 · 170 citations · Cited by this paper
  33. Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation · Kewei Ma · 2005 · 167 citations · Cited by this paper
  34. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo · Evdokia Dodou · 2003 · 158 citations · Cited by this paper
  35. Hypoxia Directs Human Extravillous Trophoblast Differentiation in a Hypoxia-Inducible Factor–Dependent Manner · Anna K. Wakeland · 2017 · 150 citations · Cited by this paper
  36. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism · Jingjing Zhang · 2014 · 124 citations · Cited by this paper
  37. Determination of the Consensus Binding Site for MEF2 Expressed in Muscle and Brain Reveals Tissue-specific Sequence Constraints · Vicente Andrés · 1995 · 119 citations · Cited by this paper
  38. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis · Chun Li Zhang · 2001 · 118 citations · Cited by this paper
  39. MEF2D - BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents · Kyogo Suzuki · 2016 · 117 citations · Cited by this paper

Source: OpenAlex (CC0)